Overview
- 2 public-safe observations are available for this inspection.
- 2 structured CFR citations are represented.
- 2 investigators are tied to this Form 483.
Inspectional observations
Each observation cites the regulation FDA found the firm out of compliance with.
21 Dec 2012
21 CFR 211.110(a)
Written in-process control procedures
Cited by Constantin Y Philopoulos, Martha Sullivan Myrick
21 Dec 2012
21 CFR 211.188(b)(12)
Investigations made into any unexplained discrepancy
Cited by Constantin Y Philopoulos, Martha Sullivan Myrick
Inspected site
CICorium Innovations, Inc.Grand Rapids, United States
Inspection team
MSMartha Sullivan Myrick
Cited regulations
CFR citations associated with this Form 483.
| Citation | What it covers | Cited |
|---|---|---|
| 21 CFR 211.110(a) | Cited across public-safe Form 483 observations | 1x |
| 21 CFR 211.188(b)(12) | Cited across public-safe Form 483 observations | 1x |
Full 483 report
Get the verbatim text of all 2 observations
Every observation in full, so your team sees exactly what was cited and how it was answered.
- The site's full inspection history around this Form 483
- Whether these citations escalated to a warning letter
- The investigators involved and the citations they repeat elsewhere